Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Triastek | 2023 | Series C | $20.5M | Nanjing |
| Qihan Biotech | 2023 | Series B | $16.0M | Hangzhou |
| Huangbaoche | 2023 | Series Unknown | $27.4M | Beijing |
| ECHINT | 2023 | Series B | $137.3M | Chengdu |
| Protoga | 2023 | Series A | $13.7M | Shenzhen |
| Cyclone Robotics | 2023 | Series C | $40.0M | Shanghai |
| Sensview | 2023 | Series A | Undisclosed | Chengdu |
| Zhenzhi Technology | 2023 | Undisclosed | Undisclosed | Qingpu |
| Ucello Therapeutics | 2023 | Series A | $21.2M | Chengdu |
| Excell Biology | 2023 | Series B | $14.4M | Shanghai |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 76 | Triastek | Series C | $20.5M | Nanjing, China |
| 77 | Qihan Biotech | Series B | $16.0M | Hangzhou, China |
| 78 | Huangbaoche | Series Unknown | $27.4M | Beijing, China |
| 79 | ECHINT | Series B | $137.3M | Chengdu, China |
| 80 | Protoga | Series A | $13.7M | Shenzhen, China |
| 81 | Cyclone Robotics | Series C | $40.0M | Shanghai, China |
| 82 | Sensview | Series A | Undisclosed | Chengdu, China |
| 83 | Zhenzhi Technology | Undisclosed | Undisclosed | Qingpu, China |
| 84 | Ucello Therapeutics | Series A | $21.2M | Chengdu, China |
| 85 | Excell Biology | Series B | $14.4M | Shanghai, China |
Triastek is a 3D printing technology startup.
Qihan Biotech is a gene-editing organ transplantation technology developer.
Huangbaoche is a travel service providing tour packages and booking services.
ECHINT offers integrated circuits board-level advanced system packaging and testing services.
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Cyclone Robotics is a provider of Robotic process automation (RPA) software and solutions.
Sensview specializes in the development and production of solid-state imaging chips and detector modules.
Zhenzhi Technology is a leading digital service management enterprise. It was incubated by Shanghai Hande Information Technology Co., Ltd.
Ucello Therapeutics is engaged in development of allogeneic cell therapies using its proprietary CAR-T cell technology platform CBT-X20.
Excell Biology is a supplier of raw materials to the biopharmaceutical and precision medicine industries.
Joes Future Food engages the development, production, testing, and sales of raw and auxiliary materials for food and biological products.
Frontis is a provider of artificial intelligence technology solutions.
Seeking Intelligent Control provides cloud-based multi-dimensional data analysis and rapid quality control equipment services.
X-EPIC is a Nanjing city-based startup aimed at building up China’s own EDA (Electronic Design Automation) industrial software technology.
Thin Red Line is a technology company building the next-generation personal computing device platform after the smartphone.
Qidi Technology is a high-tech enterprise that is early in researching, developing, and marketing 3D printers.
vesoft is the creator of the lightning-fast open-source distributed graph database #Nebula Graph#
Lansion Biotechnology is specialized in research & development, production, sell, services of in vitro diagnostic reagents and devices.
NewBanker is a wealth management technology services provider of digital intelligence, research, technology, capital and resources.
Nebula is a tech-driven firm with expertise in M&A, online retail, eCommerce, branding, and local supply chain management.
Chinese intelligent robot manipulation system provider.
Geometrical-PAL is a Chinese autonomous driving technology developer.
UNIMED provides integrated medical service models.
xuelangyun is industrial Internet platform and solution provider, focus on AI and big data
Logseq is an open-source knowledge management tool used to write and connect any type of text-based note.
Matrix Partners China has invested in 280 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Matrix Partners China's top investment sectors include Software, Biotechnology, Medical, Artificial Intelligence (AI), Manufacturing. The firm invests across 54 different industry categories.
Among tracked funding rounds, ECHINT received $137.3M in a Series B round. Matrix Partners China's total known invested capital is $6.3B.
Matrix Partners China's average investment size is $33.3M across its portfolio of 280 companies.
Recent Matrix Partners China portfolio additions include Triastek, Qihan Biotech, Huangbaoche, ECHINT, Protoga. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors